Artificial Heart Lung Machine Market (2026) | ECMO Devices, Heart Surgery, Lung Transplantation Operations & United States Growth

DataM Intelligence has released a new research report titled "Artificial-Heart Lung Machine Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Artificial-Heart Lung Machine market.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/artificial-heart-lung-machine-market?kb

United States: Recent Industry Developments
✅ March 2026: Medtronic advanced next-generation cardiopulmonary bypass systems integrating AI-based perfusion monitoring to improve surgical precision and patient safety.
✅ February 2026: LivaNova expanded U.S. manufacturing capacity for advanced ECMO and heart-lung machine circuits to meet rising demand in cardiac surgeries and critical care.
✅ January 2026: Getinge (Maquet Cardiovascular) enhanced its heart-lung bypass platforms with improved low-hemolysis oxygenators and energy-efficient perfusion systems.
✅ December 2025: Edwards Lifesciences strengthened its disposable oxygenator and perfusion component supply chain to support high-volume cardiac surgery procedures across North America.

Capitalize on high-growth Artificial-Heart Lung Machine opportunities. Connect with verified partners and make informed expansion decisions: https://www.datamintelligence.com/partner-identification-enquiry/artificial-heart-lung-machine-market?kb

List of Top Key Players 2026:

LivaNova Plc, Getinge AB, Elite LArtificial-Heart Lung Machine Market? ifeCare, Nipro Corp, Braile Biomédica, Terumo Corporation, SynCardia, Medtronic, and MAQUET GmbH & Co. KG (Getinge group).

Growth Forecast Projected 2026-2033:

The Global Artificial-Heart Lung Machine Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Key Industry Developments 2025-2026:

✅ April 2026: Hospitals and surgical centers increasingly adopted next-generation heart-lung machines with improved biocompatible coatings, enhanced oxygenation efficiency, and real-time digital monitoring to reduce intraoperative complications.

✅ March 2026: Manufacturers introduced upgraded extracorporeal circulation systems integrated with AI-assisted perfusion control, enabling better hemodynamic stability and precision during complex cardiac surgeries.

✅ February 2026: Rising demand for minimally invasive cardiac procedures accelerated deployment of compact and portable heart-lung machines designed for faster setup and improved surgical workflow efficiency.

✅ January 2026: Medical device companies enhanced product portfolios with advanced blood management systems to reduce hemolysis and improve patient safety during prolonged bypass procedures.

✅ December 2025: Hospitals expanded investments in modern cardiopulmonary bypass systems, focusing on improved oxygenation modules and automated safety alarms for high-risk surgeries.

✅ November 2025: Integration of digital perfusion analytics and remote monitoring features gained traction, enabling surgeons to track real-time patient parameters during open-heart procedures.

✅ October 2025: Increased adoption of next-generation heart-lung machines supported rising volumes of coronary artery bypass graft (CABG) and valve replacement surgeries worldwide.

How Our Market Research Process Works:

The global Artificial-Heart Lung Machine Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Artificial-Heart Lung Machine ecosystem.

Latest Mergers & Acquisitions (M & A) 2025-2026:

• April 2026: Medtronic completed acquisition of CathWorks for $585M, expanding AI-driven cardiovascular diagnostic portfolio supporting cath-lab and perfusion-related decision systems

• April 2026: Stereotaxis signed definitive agreement to acquire Robocath, strengthening robotic-assisted endovascular and cardiopulmonary intervention technologies relevant to advanced heart-lung support procedures

• April 2026: Stereotaxis-Robocath acquisition confirmed to accelerate integrated robotic systems for interventional cardiology and neurointerventions aligned with cardiopulmonary support workflows

• April 2026: Johnson & Johnson entered agreement to acquire Atraverse Medical to enhance left-heart access and RF-guided cardiac intervention systems supporting advanced cardiac surgery ecosystems

• April 2026: Stryker signed agreement to acquire Amplitude Vascular Systems to expand intravascular lithotripsy platform for complex cardiovascular and perfusion-related procedures

• January 2026: Boston Scientific agreed to acquire Penumbra ($14.5B deal) expanding cardiovascular and neurovascular intervention portfolio supporting high-acuity circulatory support procedures

• January 2026: Haemonetics acquired Vivasure Medical for €100M, strengthening minimally invasive vascular closure technologies used in extracorporeal circulation and cardiac surgery workflow

Unlock & Get Full 360° Best Strategic Market Report: https://www.datamintelligence.com/buy-now-page?report=artificial-heart-lung-machine-market?kb

Japan: Recent Industry Developments
✅ March 2026: Terumo Cardiovascular upgraded its artificial heart-lung machine systems with next-generation oxygenation membranes for improved gas exchange efficiency.
✅ February 2026: Nipro Corporation expanded production of extracorporeal circulation components, supporting increasing demand for cardiac bypass procedures and ECMO therapies.
✅ January 2026: Fukuda Denshi integrated advanced real-time monitoring technologies into perfusion systems to enhance intraoperative patient management.
✅ December 2025: Senko Medical optimized manufacturing of disposable tubing sets and perfusion circuits to improve safety and reduce contamination risks in cardiac surgeries.

Major Focused Key Segmentation (2026):

By Product Type: Single Roller pump, Double Roller pump

By Application: Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment, Others

By End-user: Hospitals, Ambulatory Surgical Centers, Others

Regional Growth Analysis for Market (2026):

⇥ North America: Leading market due to advanced cardiac care infrastructure, high adoption of ECMO systems, and strong presence of major medical device manufacturers.
⇥ Asia-Pacific (including Japan): Rapidly expanding region driven by increasing cardiac surgeries, rising healthcare investments, and growing adoption of advanced life-support technologies in hospitals across China, India, and Japan.
⇥ Europe: Strong demand supported by well-established healthcare systems, increasing cardiovascular disease prevalence, and continuous innovation in cardiopulmonary bypass technologies.
⇥ Middle East & Africa: Emerging adoption fueled by improving hospital infrastructure, rising medical tourism, and gradual integration of advanced critical care equipment in specialty centers.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Request Strategic Growth Market Customization: https://datamintelligence.com/customize/artificial-heart-lung-machine-market?kb

FAQ

Q: How fast is the market expected to grow?

A: The Artificial-Heart Lung Machine market is expected to register a strong CAGR of 4.3% during the 2024-2031

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.